Envoy Medical

COCH

Market cap $50.9M

COCH Hedge Fund Activity: Q1 2026 in Review

33 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical (COCH) for Q1 2026, worth a combined $11.5M — up 1,041% from $1.01M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new COCH positions and 6 closed out — a net gain of 8 holders — while 6 added to existing stakes and 2 trimmed.

The largest buyer was Nantahala Capital Management, opening a new position worth an estimated $5.22M. The largest seller was Citadel Advisors, exiting entirely with an estimated $58.5K sold.

• 33 institutional investors held Envoy Medical (COCH) as of Q1 2026, up from 27 in Q4 2025.
• Funds reported $11.5M of Envoy Medical stock for Q1 2026, up 1,041% quarter-over-quarter.
• 14 funds opened new Envoy Medical positions in Q1 2026 and 6 closed out, a net change of +8 holders.
• The largest Envoy Medical buyer in Q1 2026 was Nantahala Capital Management, an estimated $5.22M added.
• The largest Envoy Medical seller in Q1 2026 was Citadel Advisors, an estimated $58.5K sold.

Based on aggregated 13F filings for Q1 2026.